These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 30536408)
1. Evaluation of salivary acetylcholinesterase and pseudocholinesterase in patients with Alzheimer's disease: A case-control study. Ahmadi-Motamayel F; Goodarzi MT; Tarazi S; Vahabian M Spec Care Dentist; 2019 Jan; 39(1):39-44. PubMed ID: 30536408 [TBL] [Abstract][Full Text] [Related]
2. Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors. Sayer R; Law E; Connelly PJ; Breen KC Clin Biochem; 2004 Feb; 37(2):98-104. PubMed ID: 14725939 [TBL] [Abstract][Full Text] [Related]
3. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms. Arendt T; Brückner MK; Lange M; Bigl V Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164 [TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type. Appleyard ME; McDonald B J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405 [TBL] [Abstract][Full Text] [Related]
5. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability. Wright CI; Geula C; Mesulam MM Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355 [TBL] [Abstract][Full Text] [Related]
6. Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease. Sáez-Valero J; Fodero LR; Sjögren M; Andreasen N; Amici S; Gallai V; Vanderstichele H; Vanmechelen E; Parnetti L; Blennow K; Small DH J Neurosci Res; 2003 May; 72(4):520-6. PubMed ID: 12704813 [TBL] [Abstract][Full Text] [Related]
7. Activities and kinetic properties of lumbar cerebrospinal fluid cholinesterases in relation to clinical diagnosis, severity, and progression of Alzheimer's disease. Huff FJ; Reiter CT; Protetch J Can J Neurol Sci; 1989 Nov; 16(4):406-10. PubMed ID: 2804802 [TBL] [Abstract][Full Text] [Related]
8. Can Salivary Acetylcholinesterase be a Diagnostic Biomarker for Alzheimer? Bakhtiari S; Moghadam NB; Ehsani M; Mortazavi H; Sabour S; Bakhshi M J Clin Diagn Res; 2017 Jan; 11(1):ZC58-ZC60. PubMed ID: 28274046 [TBL] [Abstract][Full Text] [Related]
9. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus. Hamodat H; Cash MK; Fisk JD; Darvesh S Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906 [TBL] [Abstract][Full Text] [Related]
10. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Lane RM; Potkin SG; Enz A Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515 [TBL] [Abstract][Full Text] [Related]
11. Cholinesterase activity in plasma, erythrocytes, and cerebrospinal fluid of patients with dementia of the Alzheimer type. Marquis JK; Volicer L; Mark KA; Direnfeld LK; Freedman M Biol Psychiatry; 1985 Jun; 20(6):605-10. PubMed ID: 3995108 [TBL] [Abstract][Full Text] [Related]
13. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study. Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153 [TBL] [Abstract][Full Text] [Related]
14. Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease. Coleman AE; Geula C; Price BH; Mesulam MM Brain Res; 1992 Nov; 596(1-2):340-4. PubMed ID: 1467998 [TBL] [Abstract][Full Text] [Related]
15. Peripheral cholinergic disturbances in Alzheimer's disease. Rakonczay Z; Horváth Z; Juhász A; Kálmán J Chem Biol Interact; 2005 Dec; 157-158():233-8. PubMed ID: 16243305 [TBL] [Abstract][Full Text] [Related]
16. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase. Pacheco G; Palacios-Esquivel R; Moss DE J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741 [TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase protein level is preserved in the Alzheimer's brain. Campanari ML; García-Ayllón MS; Blazquez-Llorca L; Luk WK; Tsim K; Sáez-Valero J J Mol Neurosci; 2014 Jul; 53(3):446-53. PubMed ID: 24318838 [TBL] [Abstract][Full Text] [Related]
18. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840 [TBL] [Abstract][Full Text] [Related]
19. Identification and molecular characterization of propionylcholinesterase, a novel pseudocholinesterase in rice. Yamamoto K; Momonoki YS Plant Signal Behav; 2021 Nov; 16(11):1961062. PubMed ID: 34334124 [TBL] [Abstract][Full Text] [Related]
20. Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease. Sirviö J; Kutvonen R; Soininen H; Hartikainen P; Riekkinen PJ J Neural Transm; 1989; 75(2):119-27. PubMed ID: 2918304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]